Shilpa Medicare Limited

NSEI:SHILPAMED Rapporto sulle azioni

Cap. di mercato: ₹74.9b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Shilpa Medicare Gestione

Gestione criteri di controllo 4/4

Shilpa Medicare's Il CEO è Vishnukanth Bhutada, nominato in Aug2022, e ha un mandato di 36.75 anni. la retribuzione annua totale è ₹ 35.00M, composta da 100% di stipendio e 0% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 8.87% delle azioni della società, per un valore di ₹ 5.32B. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.3 anni e 2.9 anni.

Informazioni chiave

Vishnukanth Bhutada

Amministratore delegato

₹35.0m

Compenso totale

Percentuale dello stipendio del CEO100.0%
Mandato del CEO2.2yrs
Proprietà del CEO8.9%
Durata media del management2.4yrs
Durata media del Consiglio di amministrazione3.1yrs

Aggiornamenti recenti sulla gestione

Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)

Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)

Recent updates

What Shilpa Medicare Limited's (NSE:SHILPAMED) 28% Share Price Gain Is Not Telling You

Sep 12
What Shilpa Medicare Limited's (NSE:SHILPAMED) 28% Share Price Gain Is Not Telling You

Shilpa Medicare Limited's (NSE:SHILPAMED) 29% Price Boost Is Out Of Tune With Revenues

Jul 05
Shilpa Medicare Limited's (NSE:SHILPAMED) 29% Price Boost Is Out Of Tune With Revenues

What Shilpa Medicare Limited's (NSE:SHILPAMED) 27% Share Price Gain Is Not Telling You

Apr 12
What Shilpa Medicare Limited's (NSE:SHILPAMED) 27% Share Price Gain Is Not Telling You

Shilpa Medicare Limited's (NSE:SHILPAMED) Shares Climb 28% But Its Business Is Yet to Catch Up

Feb 21
Shilpa Medicare Limited's (NSE:SHILPAMED) Shares Climb 28% But Its Business Is Yet to Catch Up

Shilpa Medicare (NSE:SHILPAMED) Takes On Some Risk With Its Use Of Debt

Jan 02
Shilpa Medicare (NSE:SHILPAMED) Takes On Some Risk With Its Use Of Debt

These 4 Measures Indicate That Shilpa Medicare (NSE:SHILPAMED) Is Using Debt Extensively

Jul 17
These 4 Measures Indicate That Shilpa Medicare (NSE:SHILPAMED) Is Using Debt Extensively

Shilpa Medicare (NSE:SHILPAMED) Seems To Be Using A Lot Of Debt

Mar 17
Shilpa Medicare (NSE:SHILPAMED) Seems To Be Using A Lot Of Debt

Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)

Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)

Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Sep 07
Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Aug 14
Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Here's Why Shilpa Medicare (NSE:SHILPAMED) Is Weighed Down By Its Debt Load

Jan 27
Here's Why Shilpa Medicare (NSE:SHILPAMED) Is Weighed Down By Its Debt Load

Shareholders May Not Be So Generous With Shilpa Medicare Limited's (NSE:SHILPAMED) CEO Compensation And Here's Why

Sep 21
Shareholders May Not Be So Generous With Shilpa Medicare Limited's (NSE:SHILPAMED) CEO Compensation And Here's Why

Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

Jun 17
Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

If You Like EPS Growth Then Check Out Shilpa Medicare (NSE:SHILPAMED) Before It's Too Late

May 31
If You Like EPS Growth Then Check Out Shilpa Medicare (NSE:SHILPAMED) Before It's Too Late

Shilpa Medicare Limited's (NSE:SHILPAMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Mar 07
Shilpa Medicare Limited's (NSE:SHILPAMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Shilpa Medicare Limited (NSE:SHILPAMED) Analysts Are Reducing Their Forecasts For Next Year

Feb 20
Shilpa Medicare Limited (NSE:SHILPAMED) Analysts Are Reducing Their Forecasts For Next Year

Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

Jan 26
Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

Here's Why I Think Shilpa Medicare (NSE:SHILPAMED) Is An Interesting Stock

Jan 14
Here's Why I Think Shilpa Medicare (NSE:SHILPAMED) Is An Interesting Stock

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Vishnukanth Bhutada rispetto agli utili di Shilpa Medicare?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

₹448m

Mar 31 2024₹35m₹35m

₹319m

Dec 31 2023n/an/a

-₹7m

Sep 30 2023n/an/a

-₹119m

Jun 30 2023n/an/a

-₹321m

Mar 31 2023₹35m₹35m

-₹325m

Dec 31 2022n/an/a

₹51m

Sep 30 2022n/an/a

₹213m

Jun 30 2022n/an/a

₹599m

Mar 31 2022₹97m₹16m

₹607m

Dec 31 2021n/an/a

₹395m

Sep 30 2021n/an/a

₹376m

Jun 30 2021n/an/a

₹631m

Mar 31 2021₹97m₹16m

₹1b

Dec 31 2020n/an/a

₹2b

Sep 30 2020n/an/a

₹2b

Jun 30 2020n/an/a

₹2b

Mar 31 2020₹99m₹10m

₹2b

Dec 31 2019n/an/a

₹1b

Sep 30 2019n/an/a

₹1b

Jun 30 2019n/an/a

₹944m

Mar 31 2019₹75m₹10m

₹1b

Dec 31 2018n/an/a

₹1b

Sep 30 2018n/an/a

₹1b

Jun 30 2018n/an/a

₹1b

Mar 31 2018₹81m₹16m

₹1b

Compensazione vs Mercato: La retribuzione totale di Vishnukanth ($USD 417.34K ) è circa la media per le aziende di dimensioni simili nel mercato Indian ($USD 384.17K ).

Compensazione vs guadagni: La retribuzione di Vishnukanth è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Vishnukanth Bhutada (62 yo)

2.2yrs

Mandato

₹35,000,000

Compensazione

Mr. Vishnukanth Chaturbhuj Bhutada, B. Pharm. serves as the Managing Director of Shilpa Medicare Limited since August 11, 2022 . Mr. Bhutada joined Shilpa Medicare Limited in November 1987.He serves as th...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Vishnukanth Bhutada
MD & Director2.2yrs₹35.00m8.87%
₹ 6.6b
Alpesh Dalal
Chief Financial Officer3.4yrs₹14.73m0.0023%
₹ 1.7m
Sharath Kalakota
VP of Projects & Operations and Whole-Time Directorno data₹16.26m0.032%
₹ 24.2m
Ritu Tiwary
Company Secretary & Compliance Officer2.4yrs₹4.51mNessun dato
Jayant Karajgi
Chief Operating Officer of Formulationsno data₹26.95mNessun dato
Ganeshchandra Sonavane
President of Global R&Dno data₹11.50mNessun dato
Rajeev Saxena
Senior Vice President – Domestic Formulations and Biologicsno data₹3.90mNessun dato
Abhay Sapre
Senior Vice President of Formulationno data₹12.50mNessun dato
Smita Holey
Executive Vice President – Formulations for Small Moleculesno data₹2.50mNessun dato
Awez Pathan
Vice Presidentno data₹12.77mNessun dato
Pramod Kumar
Senior Vice President of Technicalno data₹6.06mNessun dato
P. V. Rao
Chief Human Resource Officerno dataNessun datoNessun dato

2.4yrs

Durata media

53.5yo

Età media

Gestione esperta: Il team dirigenziale di SHILPAMED è considerato esperto (durata media dell'incarico 2.3 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Vishnukanth Bhutada
MD & Director36.9yrs₹35.00m8.87%
₹ 6.6b
Sharath Kalakota
VP of Projects & Operations and Whole-Time Director5yrs₹16.26m0.032%
₹ 24.2m
Arvind Vasudeva
Non-Executive Independent Director3.1yrs₹3.00mNessun dato
Kamal Sharma
Non-Executive Independent Director2.3yrs₹3.00mNessun dato
Hetal Gandhi
Non-Executive Independent Director3.1yrs₹4.00m0.0092%
₹ 6.9m
Om Inani
Non-Executive Chairman36.6yrs₹350.00k3.3%
₹ 2.5b
Anita Bandyopadhyay
Independent Women Director2.2yrs₹1.80mNessun dato

3.1yrs

Durata media

62yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di SHILPAMED sono considerati esperti (durata media dell'incarico 3 anni).